Drug Shortage Report for MINT-GLICLAZIDE MR
| Report ID | 222750 |
| Drug Identification Number | 02423286 |
| Brand name | MINT-GLICLAZIDE MR |
| Common or Proper name | Gliclazide |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLICLAZIDE |
| Strength(s) | 30MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 count bottle |
| ATC code | A10BB |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-08 |
| Estimated end date | 2024-06-30 |
| Actual end date | 2024-11-05 |
| Shortage status | Resolved |
| Updated date | 2024-12-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-12-05 | French | Compare |
| v3 | 2024-12-05 | English | Compare |
| v2 | 2024-03-19 | French | Compare |
| v1 | 2024-03-19 | English | Compare |
Showing 1 to 4 of 4